COVID-19

As a research-driven company, we are part of the collective effort in fighting COVID-19. Boehringer Ingelheim does not develop human vaccines; however, drawing from our different areas of expertise we have engaged in a number of activities to find medical solutions to this pandemic, working closely with academic researchers, international institutions and others in the pharma industry.